Results 151 to 160 of about 51,702 (211)

Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis. [PDF]

Neurol Genet
Misicka E, Huang Y, Loomis S, Sadhu N, Fisher E, Gafson A, Runz H, Tsai E, Jia X, Herman A, Bronson PG, Bhangale T, Briggs FB.   +12 more
europepmc   +1 more source

Oratorio prolétarien

Critical Move, 2015
openaire   +2 more sources

The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function. [PDF]

CNS Drugs
Cree BAC, Berger JR, Greenberg B.
europepmc   +1 more source

Real-World Perspectives on Switching Patients with Multiple Sclerosis from Anti-CD20 Therapy to Cladribine Tablets from USA-Based Advanced Practice Providers: A Podcast. [PDF]

Adv Ther
Kutz CF, Roman C.
europepmc   +1 more source

Giovanni Maria Nanino and the Roman confraternities of his time [PDF]

, 2008
O'Regan, Noel
core  

Church Oratorio [PDF]

The Musical Times and Singing Class Circular, 1881
openaire   +1 more source

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. [PDF]

Drugs
Carlson AK, Amin M, Cohen JA.
europepmc   +1 more source

Towards Treating Multiple Sclerosis Progression. [PDF]

Pharmaceuticals (Basel)
Häusler D, Weber MS.
europepmc   +1 more source

Christmas and Twelfth Night Suggestions for Home, School, Church, Recreation Center, Club, and Community [PDF]

, 1941
Zanzig, Augustus Delafield
core